Outsourced Pharma Capacity Update Videos - Large Molecule

  1. FUJIFILM Diosynth Biotechnologies Capacity Update October 2024: Large Molecule Drug Substance 10/22/2024

    Rasmus Pedersen, Ph.D., outlines strategies to expand large-molecule production capacity to meet the global medicine demand, noting the current gap that leaves 2 billion people without access.

  2. Samsung Biologics Capacity Update October 2024: Large Molecule Drug Substance 10/22/2024

    We're poised to be your next growth engine with our commitment to quality, speed, and agility, as we expand our facilities and invest in innovative modalities to meet your large molecule needs.

  3. Cytovance Capacity Update July 2024: Large Molecule Development 9/18/2024

    Centrally located in the United States, with a decades-long history in biologics development and manufacturing, Cytovance delivers ingenuity end-to-end to both large pharma and biotech clients alike.

  4. ATON Bio Capacity Update July 2024: Large Molecule Development 8/14/2024

    Gain insights into boosting efficiency, fostering innovation, and how integrated capabilities generate value for innovators.

  5. Mabion Capacity Update July 2024: Large Molecule Development 8/14/2024

    Explore our new installations in upstream development, bioreactors, and fill-finish. This state of the art EU-GMP facility is staffed by a team of 250 professionals, and capacity is now available.

  6. Novartis Contract Manufacturing Capacity Update July 2024: Large Molecule Development 8/14/2024

    Review our capabilities in tech transfer, clinical drug substance, and commercial drug substance manufacturing across our manufacturing network in Singapore, Europe, and the US.

  7. AbbVie Capacity Update July 2024: Large Molecule Development 8/14/2024

    Delve into the intricacies of biopharmaceutical manufacturing, focusing on stages such as CLD, fermentation, and purification. We also explore process optimization and scale-up techniques.

  8. Scorpius Biomanufacturing Capacity Update July 2024: Large Molecule Development 8/14/2024

    Scorpius' VP of Manufacturing Operations Matt LeClair presents a 3D virtual tour of the process development lab, analytical and QC lab, and the mammalian manufacturing upstream and cell culture suites.

  9. KBI Biopharma Capacity Update May 2024: Large Molecule Development 6/12/2024

    Discover how our development and platform-based manufacturing solutions can create an unobstructed path to market for your large molecule pipeline in a dynamic regulatory environment.

  10. JOINN Biologics Capacity Update May 2024: Large Molecule Development 6/12/2024

    JOINN Biologics US Inc. is a California-based CDMO that provides our customers with flexible solutions for complex biologics, including ADCs. JOINN Biologics is a combination of "Big Pharma Infrastructure" with 200L and 1000L traditional stainless steel bioreactors combined with new state of the art single use bioreactors at the 50L, 200L and 500L scale.